You are here: All Products  > Innovent Acquires China Rights to Novel Immunoncology Candidate from Alector

Innovent Acquires China Rights to Novel Immunoncology Candidate from Alector

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products